Efficacy and Tolerability of Concomitant Use of Bedaquiline and Delamanid for Multidrug- and Extensively Drug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
InfectologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
- Publicado em
- 3 abr 2023
- Citações
- 18
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and Tolerability of Concomitant Use of Bedaquiline and Delamanid for Multidrug- and Extensively Drug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
Freja Breth Holmgaard, Lorenzo Guglielmetti, Troels Lillebaek, Åse Bengaard Andersen, Christian Wejse, Victor Naestholt Dahl
Descritores MeSH
- Tuberculosis, Multidrug-Resistant
- Extensively Drug-Resistant Tuberculosis
- Nitroimidazoles
- Treatment Outcome
- Antitubercular Agents
- Diarylquinolines
- Humans
- Oxazoles
Veja também
Estudos relacionados
- Hepatic Safety of Bedaquiline, Delamanid, and Pretomanid: A Systematic Review and Meta-analysis
- Efficacy and safety of bedaquiline and delamanid in the treatment of drug-resistant tuberculosis in adults: A systematic review and meta-analysis
- Favorable outcome of individual regimens containing bedaquiline and delamanid in drug-resistant tuberculosis: A systematic review
- Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis